Navigation Links
Connect the Quantum Dots

A new study, published today in the current issue of the Proceedings of the National Academy of Sciences has significant implications for the design of disease markers and the development of chemoreceptors used in human biomedical research. The groundbreaking study, entitled, "A Mechanism to Signal Receptor-Substrate Interactions with Luminescent Quantum Dots", demonstrates that quantum dots can one day replace conventional organic dyes in biomedical applications.

By using the unique photophysical properties of quantum dots, researchers Drs. Francisco Raymo, Ibrahim Yildiz, and Massimilliano Tomasulo were able to identify operating principles to probe molecular recognition events with luminescence measurements. These findings demonstrate that mechanisms based on photoinduced electron transfer can be exploited to transduce a recognition event into a significant change in the luminescence of a quantum dot. This research proves this important fundamental principle and lay the necessary groundwork for researchers to further improve its sensitivity, stability and reproducibility for biomedical applications.

"Our method has a long-term impact on biomedical diagnostic applications which currently rely on the fluorescence of organic dyes," says Francisco Raymo, Ph.D., associate professor of chemistry in the University of Miami's College of Arts and Sciences. "For example, our strategy can be designed to signal specific disease markers in biological samples thus replacing conventional organic dyes in a diversity of imaging and sensing applications."

Fluorescence microscopy and spectroscopy have become invaluable analytical tools in biomedical research but rely on the fluorescence of organic dyes which have limited luminescent properties. Quantum dots have superior photophysical properties and will presumably replace conventional organic dyes in biomedical applications. These findings will stimulate the use of quantum dots in the biomedical resea rch and development of disease markers and chemosensors.

"On its own this research paper is very significant and ahead of its time in the field of nanotechnology," says Alexey Titov, Licensing Manager for the University of Miami's Office of Technology Transfer. "However, it also has commercial applications which are a truly outstanding and rare combination."

Two patent applications have been filed by University of Miami Office of Technology Transfer on behalf of Dr. Raymo and colleagues for these inventions and the university is in the process of finding an industrial partner capable of commercializing these inventions.

Quantum dots, one of the smallest nanoscience research tools, range from 2 to 10 nanometers in diameter; nearly 3 million quantum dots would be needed to fit within the width of a thumb. By virtue of their distinct colors, quantum dots have quickly found their way into homes in many electronic lasers including the new PlayStation 3 and high-definition DVD players. Nanotechnology, the understanding and control of matter at dimensions of roughly 1 to 100 nanometers, is valuable research since matter at the nanoscale has unique properties that enable novel applications. Medical researchers work at the nano-scales can develop new drug delivery methods, therapeutics and pharmaceuticals.


Source:University of Miami Rosenstiel School of Marine & Atmospheric Science

Related biology news :

1. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
2. Quantum dots provide a faster, more sensitive method for detecting respiratory viral infections
3. Quantum dots reviewed -- Could these nanoparticles hold the cure to cancer?
4. First Quantum Grant to fund stem cell repair of damage from stroke
Post Your Comments:

(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology: